Non-invasive measurement of blood oxygen saturation
AssigneeSt. Vincent's Hospital Melbourne
InventorsBarry Dixon, Paul Randall Stoddart
Life of this patent
Estimating the term…
Loading patent…
AssigneeSt. Vincent's Hospital Melbourne
InventorsBarry Dixon, Paul Randall Stoddart
Estimating the term…
A method for non-invasive determination of oxygen saturation of blood within a deep vascular structure of a human or animal patient comprising locating on skin of the patient in a vicinity of the deep vascular structure of interest emitter and receiver elements of a light oximeter device, wherein optimal location of said elements is achieved through matching of a plethysmography trace obtained from the oximeter device to known plethysmography characteristics of the deep vascular structure of interest, wherein the emitter element emits light at wavelengths of from about 1045 nm to about 1055 nm and from about 1085 nm to about 1095 nm, and wherein oxygen saturation is determined from a ratio of light absorbed at these two wave-lengths by haemoglobin in blood within the vascular structure of interest.
A method for non-invasive determination of oxygen saturation of blood within a deep vascular structure of a human or animal patient comprising locating on skin of the patient in a vicinity of the deep vascular structure of interest emitter and receiver elements of a light oximeter device, wherein optimal location of said elements is achieved through matching of a plethysmography trace obtained from the oximeter device to known plethysmography characteristics of the deep vascular structure of interest, wherein the emitter element emits light at wavelengths of from about 1045 nm to about 1055 nm and from about 1085 nm to about 1095 nm, and wherein oxygen saturation is determined from a ratio of light absorbed at these two wavelengths by haemoglobin in blood within the vascular structure of interest.
A method for non-invasive determination of oxygen saturation of blood within a deep vascular structure of a human or animal patient comprising locating within the external auditory canal of the patient in a vicinity of the internal jugular vein and/or sigmoid sinus emitter and receiver elements of a light oximeter device, wherein optimal location of said elements is achieved through matching of a plethysmography trace obtained from the oximeter device to known plethysmography characteristics of the internal jugular vein and/or sigmoid sinus, wherein oxygen saturation is determined from a ratio of light absorbed at different wavelengths by haemoglobin in blood within the internal jugular vein and/or sigmoid sinus.
A method for non-invasive determination of oxygen saturation of blood within a deep vascular structure of a human or animal patient comprising locating within the external auditory canal of the patient in a vicinity of the internal jugular vein emitter and receiver elements of a light oximeter device, wherein optimal location of said elements is achieved through matching of a plethysmography trace obtained from the oximeter device to known plethysmography characteristics of the internal jugular vein, wherein the emitter element emits light at wavelengths of from about 1045 nm to about 1055 nm and from about 1085 nm to about 1095 nm, and wherein oxygen saturation is determined from a ratio of light absorbed at these two wavelengths by haemoglobin in blood within the internal jugular vein.
An oximetry device comprising a central processing unit, a display and emitter and receiver elements adapted for releasable application to human or animal skin, all of which are workably connected in use;
Dependencies are inferred from the claim text.